Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection

by Jenny Clarke, Murielle Baltazar, Mansoor Alsahag, Stavros Panagiotou, Marion Pouget, William A. Paxton, Georgios Pollakis, Dean Everett, Neil French, Aras Kadioglu
Published 2021

Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity

by Stavros Panagiotou, Chrispin Chaguza, Reham Yahya, Teerawit Audshasai, Murielle Baltazar, Lorenzo Ressel, Shadia Khandaker, Mansoor Alsahag, Tim J. Mitchell, Marc Prudhomme, Aras Kadioglu, Marie Yang
Published 2021

Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin

by Laura C. Jacques, Stavros Panagiotou, Murielle Baltazar, Madikay Senghore, Shadia Khandaker, Rong Xu, Laura Bricio-Moreno, Marie Yang, Christopher G. Dowson, Dean B. Everett, Daniel R. Neill, Aras Kadioglu
Published 2020